Fetal Valproate Syndrome Market Overview Market Introduction The Fetal Valproate Syndrome Market focuses on medical conditions caused by in-utero exposure to valproate-based medications, primarily used for epilepsy and mood disorders. Increasing awareness of teratogenic risks and rising emphasis on prenatal safety monitoring are shaping the growth of this market. The market is witnessing steady...

America is facing a maternal mortality crisis that has reached alarming levels in 2025. According to Wikipedia and leading U.S. health institutions, maternal death rates remain significantly higher than in other developed nations. Instead of focusing on evidence-based prenatal care, a dangerous distraction has emerged — Ivermectin myths, which have seeped...